Search research articles
Contact Us
Filters
Showing results (41-50 of 132) with videos related to
Page
of 14
Sort By:
Diabetes
|
August 1, 1985
Two-year experience with continuous subcutaneous insulin infusion in relation to retinopathy and neuropathy
T Lauritzen, K Frost-Larsen, H W Larsen, et al.
Acta Endocrinologica
|
February 1, 1984
Absorption of soluble and isophane semi-synthetic human and porcine insulin in insulin-dependent diabetic subjects
S Pramming, T Lauritzen, B Thorsteinsson, et al.
Diabetic Medicine : a Journal of the British Diabetic Association
|
August 30, 2007
Are lifestyle changes achieved after participation in a screening programme for Type 2 diabetes? The ADDITION Study, Denmark
K S Mai, A Sandbaek, K Borch-Johnsen, et al.
The Journal of Clinical Endocrinology and Metabolism
|
June 1, 1990
Pulsatile versus continuous intravenous administration of growth hormone (GH) in GH-deficient patients: effects on circulating insulin-like growth factor-I and metabolic indices
J O Jørgensen, N Møller, T Lauritzen, et al.
Diabetologia
|
February 23, 2011
HbA1c and cardiovascular risk score identify people who may benefit from preventive interventions: a 7 year follow-up of a high-risk screening programme for diabetes in primary care (ADDITION), Denmark
T Lauritzen, A Sandbaek, M V Skriver, et al.
Diabetologia
|
September 15, 2004
Population-based stepwise screening for unrecognised Type 2 diabetes is ineffective in general practice despite reliable algorithms
J O Christensen, A Sandbaek, T Lauritzen, et al.
Diabetologia
|
August 11, 2010
HbA1c as predictor of all-cause mortality in individuals at high risk of diabetes with normal glucose tolerance, identified by screening: a follow-up study of the Anglo-Danish-Dutch Study of Intensive Treatment in People with Screen-Detected Diabetes in Primary Care (ADDITION), Denmark
M V Skriver, K Borch-Johnsen, T Lauritzen, et al.
Diabetes, Obesity & Metabolism
|
October 10, 2006
Multiple mealtime administration of biphasic insulin aspart 30 versus traditional basal-bolus human insulin treatment in patients with type 1 diabetes
J-W Chen, T Lauritzen, A Bojesen, et al.
Growth Hormone & IGF Research : Official Journal of the Growth Hormone Research Society and the International IGF Research Society
|
October 8, 2013
Circadian variation in the pharmacokinetics of steady state continuous subcutaneous infusion of growth hormone in adult growth hormone deficient patients
J Janukonyté, T Parkner, T Lauritzen, et al.
British Medical Journal (Clinical Research Ed.)
|
July 17, 1982
Absorption of isophane (NPH) insulin and its clinical implications
T Lauritzen, S Pramming, E A Gale, et al.
Page
of 14
Search research articles
Search
Showing results (41-50 of 132) with videos related to
Sort By:
Page
of 14
Diabetes
|
August 1, 1985
Two-year experience with continuous subcutaneous insulin infusion in relation to retinopathy and neuropathy
T Lauritzen, K Frost-Larsen, H W Larsen, et al.
Acta Endocrinologica
|
February 1, 1984
Absorption of soluble and isophane semi-synthetic human and porcine insulin in insulin-dependent diabetic subjects
S Pramming, T Lauritzen, B Thorsteinsson, et al.
Diabetic Medicine : a Journal of the British Diabetic Association
|
August 30, 2007
Are lifestyle changes achieved after participation in a screening programme for Type 2 diabetes? The ADDITION Study, Denmark
K S Mai, A Sandbaek, K Borch-Johnsen, et al.
The Journal of Clinical Endocrinology and Metabolism
|
June 1, 1990
Pulsatile versus continuous intravenous administration of growth hormone (GH) in GH-deficient patients: effects on circulating insulin-like growth factor-I and metabolic indices
J O Jørgensen, N Møller, T Lauritzen, et al.
Diabetologia
|
February 23, 2011
HbA1c and cardiovascular risk score identify people who may benefit from preventive interventions: a 7 year follow-up of a high-risk screening programme for diabetes in primary care (ADDITION), Denmark
T Lauritzen, A Sandbaek, M V Skriver, et al.
Diabetologia
|
September 15, 2004
Population-based stepwise screening for unrecognised Type 2 diabetes is ineffective in general practice despite reliable algorithms
J O Christensen, A Sandbaek, T Lauritzen, et al.
Diabetologia
|
August 11, 2010
HbA1c as predictor of all-cause mortality in individuals at high risk of diabetes with normal glucose tolerance, identified by screening: a follow-up study of the Anglo-Danish-Dutch Study of Intensive Treatment in People with Screen-Detected Diabetes in Primary Care (ADDITION), Denmark
M V Skriver, K Borch-Johnsen, T Lauritzen, et al.
Diabetes, Obesity & Metabolism
|
October 10, 2006
Multiple mealtime administration of biphasic insulin aspart 30 versus traditional basal-bolus human insulin treatment in patients with type 1 diabetes
J-W Chen, T Lauritzen, A Bojesen, et al.
Growth Hormone & IGF Research : Official Journal of the Growth Hormone Research Society and the International IGF Research Society
|
October 8, 2013
Circadian variation in the pharmacokinetics of steady state continuous subcutaneous infusion of growth hormone in adult growth hormone deficient patients
J Janukonyté, T Parkner, T Lauritzen, et al.
British Medical Journal (Clinical Research Ed.)
|
July 17, 1982
Absorption of isophane (NPH) insulin and its clinical implications
T Lauritzen, S Pramming, E A Gale, et al.
Page
of 14